Lista de

Antigens, Neoplasm
9
"Human MageB2 protein expression enhances E2F transcriptional activity, cell proliferation, and resistance to ribotoxic stress" (2015) Peche, L.Y.;Ladelfa, M.F.;Toledo, M.F. (...)Monte, M. Journal of Biological Chemistry. 290(49):29652-29662
"Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells" (2010) Zwirner, N.W.; Croci, D.O.; Domaica, C.I.; Rabinovich, G.A. Current Pharmaceutical Design. 16(3):255-267
"Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells" (2005) Liu, K.;Idoyaga, J.;Charalambous, A. (...)Steinman, R.M. Journal of Experimental Medicine. 202(11):1507-1516
"Regulation of HLA-DR antigen in monocytes from colorectal cancer patients by in vitro treatment with human recombinant interferon-γ" (2000) Novellino, P.S.;Trejo, Y.G.;Beviacqua, M. (...)Rumi, L.S. Journal of Investigational Allergology and Clinical Immunology. 10(2):90-93
"Forskolin induces U937 cell line differentiation as a result of a sustained cAMP elevation" (1998) Brodsky, A.;Davio, C.;Shayo, C. (...)Rivera, E. European Journal of Pharmacology. 350(1):121-127
"The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo." (1998) Bover, L.;Barrio, M.;Bravo, A.I. (...)Mordoh, J. Cellular and molecular biology (Noisy-le-Grand, France). 44(3):493-504
"Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells" (1995) Ballaré, C.; Barrio, M.; Portela, P.; Mordoh, J. Cancer Immunology Immunotherapy. 41(1):15-22